Jaime Bartushak - 10 Oct 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Financial Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
10 Oct 2023
Net transactions value
$0
Form type
4
Filing time
12 Oct 2023, 16:15:24 UTC
Previous filing
06 Oct 2022
Next filing
14 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 60,353 10 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300,000 $0.000000 300,000 10 Oct 2023 Common Stock 300,000 $0.7000 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 10 Oct 2023 Common Stock 300,000 $1.25 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 10 Oct 2023 Common Stock 300,000 $2.04 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 100,000 10 Oct 2023 Common Stock 100,000 $2.00 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 125,000 10 Oct 2023 Common Stock 125,000 $1.01 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 100,000 10 Oct 2023 Common Stock 100,000 $0.6700 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 70,000 10 Oct 2023 Common Stock 70,000 $1.62 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 25,000 10 Oct 2023 Common Stock 25,000 $3.45 Direct F8
holding CTXR Stock Option (Right to Purchase Common Stock) 48,267 10 Oct 2023 Common Stock 48,267 $10.50 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F2 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F3 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F4 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F5 The options vested in full on October 6, 2023.
F6 The options vested in full on October 8, 2022.
F7 The options vested in full on September 4, 2021.
F8 the options vested in full on September 12, 2020.
F9 The options vested in full on July 7, 2019.